Cipla
D2C
India D2C Summit 2023: The country’s D2C market to soon touch $60 billion
The country’s D2C segment currently accounts for 20% of e-commerce, and it is projected to grow to 40% according to experts speaking at the second edition of India D2C Summit 2023
Mumbai: There is high optimism for the country’s D2C...
Food
Swiggy expands essential services to over 125 cities
Food ordering and delivery platform Swiggy on Monday said it has expanded delivery of groceries and household essential services to over 125 cities and has also tied up with a number of national brands and retailers.
The company has partnered...
Retail
Pharma market to suffer loss of Rs 1k cr post ban
It is expected that the pharmaceutical market will have to suffer an immediate loss of Rs 800-1,000 crore impacting about 2,500 brands on retail shelves as well as in transit, as more drug makers moved court against the Government's...
Beauty & Wellness
Dr Reddy’s bags licensing deals with Cipla and Vitabiotics
Indian Pharma major, Dr Reddy's Laboratories, has entered into an agreement with Cipla, an Indian pharmaceutical company, to exclusively market some of its products in the over-the-counter and prescription segment in Russia and Ukraine. The agreement allows the...
Retail
Cipla tops drugs retail sales
Drug manfacturer Cipla was the top-selling drug maker in the domestic retail market for the past three months heading the chart in September pushing Ranbaxy Laboratories to second spot, market research figures showed.
According to the market research firm ORG...
- Advertisement -
Latest News
The Luxottica report card for 2022
A look at how the world’s largest eyewear company fared in terms of revenue growth in key regions across...
- Advertisement -
